Long‐Term Quality of Life in Patients with Intracanalicular Vestibular Schwannomas after Gamma Knife Surgery Treatment: A Follow‐Up Study

Author:

Ząbek MirosławORCID,Turek GrzegorzORCID,Bieńkowska KatarzynaORCID,Kokoszka AndrzejORCID,Dzierzęcki SebastianORCID,Kostecka BarbaraORCID

Abstract

Introduction. Our previous research showed that the gamma knife surgery (GKS) is a highly effective treatment for intracanalicular vestibular schwannomas (IVS). In the current study, we aimed to evaluate long‐term quality of life (QoL) as a follow‐up to the assessment of baseline clinical and demographic parameters in the original study. Moreover, QoL outcomes were compared with norms for the general population and for patients who underwent different ear, nose, and throat (ENT) procedures. Materials and Methods. The follow‐up study included 92 patients (59 women and 33 men; mean age, 61.71 ± 12.55 years; range: 32‐85 years) with unilateral IVS who underwent GKS. Patients completed the Assessment of Quality of Life, Penn Acoustic Neuroma Quality‐of‐Life, Glasgow Benefit Inventory, and WHO‐5 Well‐being Index questionnaires as well as a demographic survey. Neurosurgical parameters were assessed using the Koos and House‐Brackmann scales and the results of audiological examinations. Results and Conclusions. QoL scores were within or above the norm in 38% of patients. There were significant differences in terms of comorbidities and emotional well‐being between patients with QoL scores within or above the norm and patients with QoL scores below the norm. Comorbidities were more common in patients with QoL scores below the norm, and they influenced reported QoL (p = 0.009). Patients with QoL scores within or above the norm reported better emotional well‐being than those with QoL scores below the norm. Long‐term QoL outcomes were satisfactory, consistent with the results of the original study. Although GKS is a complex procedure, patients reported higher QoL than those using hearing aids and the same QoL as those after ENT surgery or reassurance. However, they reported a slightly lower QoL than patients taking ENT medications. GKS appears to be a promising treatment option for patients with IVS.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3